Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-24

Clinical Trial Update: Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative short-course radiotherapy combined with Envafolimab, Endostatin, and the SOX regimen for locally advanced gastric/gastroes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endostatin (endostatin)
  • Envafolimab (envafolimab)
  • SOX regimen (S-1 and oxaliplatin)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Gastric/Gastroesophageal Junction Adenocarcinoma, Radiotherapy | Phase 2 | Status: UNKNOWN